<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-14-10455</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0105410</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Nutrition</subject></subj-group><subj-group><subject>Physiology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and health sciences</subject><subj-group><subject>Endocrinology</subject></subj-group><subj-group><subject>Metabolic disorders</subject></subj-group><subj-group><subject>Women's health</subject></subj-group></subj-group></article-categories>
<title-group>
<article-title>Adaptive Human <italic>CDKAL1</italic> Variants Underlie Hormonal Response Variations at the Enteroinsular Axis</article-title>
<alt-title alt-title-type="running-head">Adaptive <italic>CDKAL1</italic> Variants and Enteroinsular Response</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chang</surname><given-names>Chia Lin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cai</surname><given-names>James J.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Huang</surname><given-names>Shang Yu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cheng</surname><given-names>Po Jen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chueh</surname><given-names>Ho Yen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hsu</surname><given-names>Sheau Yu Teddy</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital Linkou Medical Center, Chang Gung University, Kweishan, Taoyuan, Taiwan</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, Texas, United States of America</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Reproductive Biology and Stem Cell Research Program, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Maedler</surname><given-names>Kathrin</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Bremen, Germany</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">amego@cgmh.org.tw</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: CLC SYTH. Performed the experiments: CLC JJC PJC HYC SYH SYTH. Analyzed the data: CLC JJC SYTH. Contributed reagents/materials/analysis tools: CLC JJC PJC HYC SYH SYTH. Wrote the paper: CLC JJC SYTH.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>15</day><month>9</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>9</issue>
<elocation-id>e105410</elocation-id>
<history>
<date date-type="received"><day>8</day><month>3</month><year>2014</year></date>
<date date-type="accepted"><day>22</day><month>7</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Chang et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>Recent analyses have identified positively selected loci that explain differences in immune responses, body forms, and adaptations to extreme climates, but variants that describe adaptations in energy-balance regulation remain underexplored. To identify variants that confer adaptations in energy-balance regulation, we explored the evolutionary history and functional associations of candidate variants in 207 genes. We screened single nucleotide polymorphisms in genes that had been associated with energy-balance regulation for unusual genetic patterns in human populations, followed by studying associations among selected variants and serum levels of GIP, insulin, and C-peptide in pregnant women after an oral glucose tolerance test. Our analysis indicated that 5′ variants in <italic>CDKAL1, CYB5R4</italic>, <italic>GAD2</italic>, and <italic>PPARG</italic> are marked with statistically significant signals of gene–environment interactions. Importantly, studies of serum hormone levels showed that variants in <italic>CDKAL1</italic> are associated with glucose-induced GIP and insulin responses (<italic>p</italic>&lt;0.05). On the other hand, a <italic>GAD2</italic> variant exhibited a significant association with glucose-induced C-peptide response. In addition, simulation analysis indicated that a type 2 diabetes risk variant in <italic>CDKAL1</italic> (rs7754840) was selected in East Asians ∼6,900 years ago. Taken together, these data indicated that variants in <italic>CDKAL1</italic> and <italic>GAD2</italic> were targets of prior environmental selection. Because the selection of the <italic>CDKAL1</italic> variant overlapped with the selection of a cluster of <italic>GIP</italic> variants in the same population ∼11,800 to 2,000 years ago, we speculate that these regulatory genes at the human enteroinsular axis could be highly responsive to environmental selection in recent human history.</p>
</abstract>
<funding-group><funding-statement>This work was supported in part by grants from National Science Council (NSC 102-2314-B-182A-086, CLC); Chang Gung Memorial Hospital (CMRPG391151-3, CLC); National Institute of Health (DK70652, SYTH); and Avon Foundation (02-2009-054, SYTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="9"/></counts><custom-meta-group><custom-meta id="data-availability" xlink:type="simple"><meta-name>Data Availability</meta-name><meta-value>The authors confirm that all data underlying the findings are fully available without restriction. All data are included within the manuscript.</meta-value></custom-meta></custom-meta-group></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Because of the recency of our common ancestry, it is well accepted that the investigation of positively selected single nucleotide polymorphisms (SNPs) in human populations may explain arrays of phenotypic variation in humans. Indeed, recent studies have identified hundreds of loci that exhibit evidences of positive selection in human genomes, and uncovered variants that describe variations in appearance, physiological adaptations, and pathological responses to diseases, thereby providing a better understanding of the molecular mechanisms that underlie these selections <xref ref-type="bibr" rid="pone.0105410-Leslie1">[1]</xref>, <xref ref-type="bibr" rid="pone.0105410-Simonson1">[2]</xref>, <xref ref-type="bibr" rid="pone.0105410-Tishkoff1">[3]</xref>, <xref ref-type="bibr" rid="pone.0105410-Voight1">[4]</xref>. However, genetic variants that confer adaptations in energy-balance regulation remain underexplored. Because such variants were likely subject to selection pressures that fluctuated over time, a moderate signal of selection could be all that has remained as a clue to selection. Accordingly, we screened gene region SNPs for unusual patterns in derived allele frequency and linkage disequilibrium (LD) in genes that had been associated with energy-balance regulation (i.e., past clinical investigations, genome-wide association (GWA) studies, and quantitative trait loci analyses) <xref ref-type="bibr" rid="pone.0105410-Chang1">[5]</xref>, <xref ref-type="bibr" rid="pone.0105410-Chang2">[6]</xref>.</p>
<p>In these studies, we identified common 5′ variants in five genes—glucose-dependent insulinotropic polypeptide (<italic>GIP</italic>), Cdk5 regulatory associated protein 1-like 1 (<italic>CDKAL1</italic>), cytochrome b5 reductase 4 (<italic>CYB5R4</italic>), glutamate decarboxylase 2 (<italic>GAD2</italic>), and peroxisome proliferator-activated receptor gamma (<italic>PPARG</italic>)—as top metabolic modifier candidates. With the exception of <italic>GAD2</italic> variant rs2236418, none of the candidate variants had been implicated in earlier GWA studies although <italic>CDKAL1, CYB5R4</italic>, and <italic>PPARG</italic> loci have been associated with diabetes- and/or obesity-related traits <xref ref-type="bibr" rid="pone.0105410-Hansen1">[7]</xref>, <xref ref-type="bibr" rid="pone.0105410-Pascoe1">[8]</xref>, <xref ref-type="bibr" rid="pone.0105410-Steinthorsdottir1">[9]</xref>, <xref ref-type="bibr" rid="pone.0105410-Witchel1">[10]</xref>, <xref ref-type="bibr" rid="pone.0105410-Xie1">[11]</xref>, <xref ref-type="bibr" rid="pone.0105410-Boutin1">[12]</xref>. It is possible that these variants operate under physiological conditions that have not been specifically investigated. Consistent with the hypothesis, our recent studies have shown that three regulatory <italic>GIP</italic> variants were positively selected ∼8,100 (11,800 to 2,000) years ago, and are associated with variations in glucose metabolism and glucose-induced GIP response in pregnant women; moreover, a coding <italic>GIP</italic> variant (rs2291725) affects the bioactivity of GIP <xref ref-type="bibr" rid="pone.0105410-Chang1">[5]</xref>, <xref ref-type="bibr" rid="pone.0105410-Chang2">[6]</xref>.</p>
<p>To gain a better understanding of whether and how <italic>CDKAL1, CYB5R4</italic>, <italic>GAD2</italic>, and <italic>PPARG</italic> variants contribute to adaptations in energy-balance regulation, we further explored their evolutionary history and potential genotype–phenotype relationships in humans.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Ethics Statement and Patients</title>
<p>The study was approved by the institutional ethics committee review board of Chang Gung Memorial Hospital Linkou Medical Center, and was conducted in accordance with the guidelines in The Declaration of Helsinki. A total of 131 unrelated healthy women with normal pregnancy were recruited, and all patients gave written informed consent to participate in the study. Related patients (i.e., blood relatives) were excluded to ensure that the observed associations were not due to confounding effects from ancestry. The screening glucose challenge test for gestational diabetes mellitus (GDM) was performed as previously described <xref ref-type="bibr" rid="pone.0105410-Kjos1">[13]</xref>. Specifically, patients were given a 50-gram glucose solution after overnight fasting at 23–29 weeks of gestation, and a blood sample was taken at 1 hour after glucose intake. The mean age and body mass index (BMI) of patients were 30.7±0.4 years and 25.4±0.3, respectively.</p>
</sec><sec id="s2b">
<title>Genotyping</title>
<p>Genomic DNA samples of subjects were extracted and purified from anticoagulated blood with the DNeasy Blood &amp; Tissue Kit (Qiagen). Genotyping of SNPs was performed using the Applied Biosystems TaqMan Validated SNP Genotyping Assays. The genotyping analysis had a &gt;96% success rate and &gt;99% reproducibility.</p>
</sec><sec id="s2c">
<title>Measurements and statistical analysis of circulatory levels of GIP, insulin, and C-peptide</title>
<p>Blood samples were collected from patients 1 hr after administration of the oral glucose tolerance test (OGTT). Serum GIP, insulin, and C-peptide levels were measured using specific ELISA kits from Millipore, Mercodia, and Calbiotech, respectively. Patients' serum hormone profiles were analyzed by the χ<sup>2</sup> test, the Student's <italic>t</italic>-test, or linear regression analysis using GraphPad Prism 5. All <italic>p</italic>-values were two-sided. The statistical significance cutoff value was 0.05.</p>
</sec><sec id="s2d">
<title>F<sub>ST</sub> estimation and analysis of haplotypes</title>
<p>To identify adaptive SNPs, we screened for common gene region variants that have divergent allele frequencies in HapMap populations in 207 candidate genes <xref ref-type="bibr" rid="pone.0105410-TheInternationalHapMapProject1">[14]</xref>. To improve the odds of identifying potential genotype–phenotype relationships, we focused on SNPs with a &gt;30% minor allele frequency (MAF) in the overall Eurasian (CEU [U.S. residents with northern and western European ancestry] and ASN [pooled samples of Chinese from Beijing [CHB] and Japanese from Tokyo [JPT]) populations. The population genetic differentiation statistic F<sub>ST</sub> among HapMap II populations (i.e., CEU, ASN, and YRI [Yoruba from Ibadan]) was computed using the PGEToolbox and SPSmart <xref ref-type="bibr" rid="pone.0105410-Cai1">[15]</xref>, <xref ref-type="bibr" rid="pone.0105410-Amigo1">[16]</xref>. Putative positive SNPs (i.e., those in the top 10%) were further analyzed using pairwise population comparisons. The use of F<sub>ST</sub> is advantageous given that F<sub>ST</sub> measures the proportion of total genetic variance that is caused by differences among populations, and does not require assumptions about the structure of human populations and SNP ascertainment bias. In addition, LD blocks and haplotype plots were analyzed using HaploView 4.1 <xref ref-type="bibr" rid="pone.0105410-Barrett1">[17]</xref>.</p>
</sec><sec id="s2e">
<title>Analysis of EHH and iHS statistics</title>
<p>We computed the extended haplotype homozygosity (EHH) statistic for SNPs as previously described <xref ref-type="bibr" rid="pone.0105410-Sabeti1">[18]</xref>, and the EHH plots were generated as described <xref ref-type="bibr" rid="pone.0105410-Voight1">[4]</xref>. The EHH curve depicts the decay of identity of haplotypes that carry alleles of a core SNP as a function of distance between tested SNPs and the core SNP. When an allele rises rapidly in frequency due to positive selection, it tends to exhibit a high haplotype homozygosity that extends further than expected in a neutral model. For the analysis of EHH decay, haplotypes in the genomic region centered on select SNPs were downloaded from the HapMap project website.</p>
<p>The integrated Haplotype Score (iHS) statistic detects whether the area under the EHH curve for a selected allele is greater than that for a neutral allele; it is a measure of recent positive selection for variants that have not yet reached fixation <xref ref-type="bibr" rid="pone.0105410-Voight1">[4]</xref>. To test whether the observed iHS deviated significantly from the expected neutral values, we used a coalescent model and generated 10,000 replicated haplotype sets using the coalescent simulator ms <xref ref-type="bibr" rid="pone.0105410-Hudson1">[19]</xref>. We adopted simulation parameters compatible with the sample size of the population and the length of the genomic region that was analyzed. The simulation was conditioned based on the same recombination rate and the number of segregating sites within tested regions.</p>
</sec><sec id="s2f">
<title>Estimation of the age of selected allele</title>
<p>When a novel allele is positively selected, the allele and its linked haplotype quickly rise to a high frequency. As the allele ages, the length of the haplotype shortens over time due to recombination and mutation. By modelling this process and measuring the decay of the haplotype that carries the positively selected allele, the age of the allele can be estimated <xref ref-type="bibr" rid="pone.0105410-Stephens1">[20]</xref>. The breakdown of the intactness of the haplotype surrounding the selected allele was modeled using a Poisson process as described earlier <xref ref-type="bibr" rid="pone.0105410-Reich1">[21]</xref>. We obtained the recombination map from the FTP site of the HapMap project (<ext-link ext-link-type="uri" xlink:href="ftp://ftp.ncbi.nlm.nih.gov/hapmap/recombination/" xlink:type="simple">ftp://ftp.ncbi.nlm.nih.gov/hapmap/recombination/</ext-link>). The rs7754840 block consists of 70 SNPs, and is represented by 11 distinct haplotypes in ASN; among which haplotypes 1, 6, and 8–10 carry the derived allele C of rs7754840 (Fig. S1 in <xref ref-type="supplementary-material" rid="pone.0105410.s001">File S1</xref>, upper left panel). Among these derived haplotypes, haplotype 1 with a frequency of 0.259 is apparently the ancestral haplotype, from which haplotypes 6 and 8–10—with frequencies of 0.029, 0.018, 0.015, and 0.015, respectively—were derived. The relative portion of haplotype 1 (the ancestral haplotype) of all derived haplotypes is <italic>P</italic>' = 0.77.</p>
<p>The recombination map correlates the increment of physical distance (Mb) with that of genetic distance (cM), which is derived from the estimates of LD between HapMap SNPs <xref ref-type="bibr" rid="pone.0105410-McVean1">[22]</xref>. We took the mutation rate of the region <italic>u</italic> = 1.66×10<sup>−6</sup>—based on the haploid mutation rate of 1.1×10<sup>−8</sup> per base per generation <xref ref-type="bibr" rid="pone.0105410-Roach1">[23]</xref> and the probability of ascertaining HapMap SNPs, ∼10<sup>−3</sup>—for the analysis. We assumed that the most common haplotype is the ancestral haplotype and used <italic>P</italic>' as an approximation of <italic>P</italic>.</p>
<p>The probability that a haplotype remains ancestral (i.e., that the haplotype that carries the derived allele retains the status of high frequency right after being selected) is <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0105410.e001" xlink:type="simple"/></inline-formula>, where <italic>G</italic> is the number of generations, <italic>r</italic> is the recombination rate per generation, and <italic>μ</italic> is the mutation rate per generation. For a given allele in the derived haplotype, the haplotype-decay approach estimates the number of generations <italic>G</italic> in terms of <italic>P</italic> (the probability that a given haplotype does not change from its ancestor) <xref ref-type="bibr" rid="pone.0105410-Stephens1">[20]</xref>, <xref ref-type="bibr" rid="pone.0105410-Reich1">[21]</xref>.</p>
<p>In these analyses, the hypothetical demographic history assumed that the ASN population is one panmictic population that underwent a size reduction, followed by a period of constant size. The population had an ancestral population size of N1, which at time T2 instantaneously shrank to size N2. It remained constant at size N2 until time T1, at which point it began expanding exponentially until the present time. The population size at the present time is N3 (i.e., the bottleneck model) <xref ref-type="bibr" rid="pone.0105410-Gutenkunst1">[24]</xref>.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Common 5′ variants in <italic>CDKAL1</italic>, <italic>CYB5R4</italic>, <italic>GAD2</italic>, and <italic>PPARG</italic> exhibit signals of selection</title>
<p>Studies of allele frequency of genic region SNPs in 207 candidate genes showed that, in addition to a cluster of 37 linked <italic>GIP</italic> SNPs <xref ref-type="bibr" rid="pone.0105410-Chang2">[6]</xref>, common variants in the 5′ proximate region of <italic>CDKAL1</italic> (rs9368197, position -1305 nt), <italic>CYB5R4</italic> (rs1325471, position -1695 nt), <italic>GAD2</italic> (rs2236418, position -243nt), and <italic>PPARG</italic> (rs2920502, position −154 nt) exhibit highly skewed population frequency in YRI, CEU, and ASN populations (<xref ref-type="table" rid="pone-0105410-t001">Table 1</xref>) <xref ref-type="bibr" rid="pone.0105410-Chang1">[5]</xref>, <xref ref-type="bibr" rid="pone.0105410-TheInternationalHapMapProject1">[14]</xref>. The differences in derived allele frequency between African (YRI) and Eurasian (i.e., CEU and ASN) populations are in excess of 45–70%. For example, the derived allele of <italic>PPARG</italic> rs2920502 increased from 2.6% in YRI to 35.7% and 75.3% in CEU and ASN, respectively.</p>
<table-wrap id="pone-0105410-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0105410.t001</object-id><label>Table 1</label><caption>
<title>Gene region candidate SNPs that exhibited signs of selection.</title>
</caption><alternatives><graphic id="pone-0105410-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0105410.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Gene (Candidate SNPs)</td>
<td align="left" rowspan="1" colspan="1">Association with disease risk<xref ref-type="table-fn" rid="nt101">a</xref></td>
<td align="left" rowspan="1" colspan="1">Posi-tion (hg18)</td>
<td colspan="3" align="left" rowspan="1">Frequencies of derived alleles</td>
<td align="left" rowspan="1" colspan="1">Frequency differentiation (F<sub>ST</sub>)</td>
<td align="left" rowspan="1" colspan="1">Allele (anc/der)</td>
<td align="left" rowspan="1" colspan="1">Extended haplotype homozygosity</td>
</tr>
<tr>
<td colspan="3" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">YRI</td>
<td align="left" rowspan="1" colspan="1">CEU</td>
<td align="left" rowspan="1" colspan="1">ASN</td>
<td colspan="3" align="left" rowspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>CDKAL1</italic></bold> (rs9368197)</td>
<td align="left" rowspan="1" colspan="1">T2D, ulcerative colitis, GDM, Crohn's, OB</td>
<td align="left" rowspan="1" colspan="1">Chr. 6, 20641k</td>
<td align="left" rowspan="1" colspan="1">0.051</td>
<td align="left" rowspan="1" colspan="1">0.233</td>
<td align="left" rowspan="1" colspan="1">0.511</td>
<td align="left" rowspan="1" colspan="1">F<sub>ST (YRI-CEU)</sub>  = 0.11 F<sub>ST (YRI-ASN)</sub>  = 0.44 F<sub>ST (CEU-ASN)</sub>  = 0.14</td>
<td align="left" rowspan="1" colspan="1">G/T</td>
<td align="left" rowspan="1" colspan="1">iHS <sub>(YRI)</sub>  =  N.D. iHS <sub>(CEU)</sub>  = −0.67<xref ref-type="table-fn" rid="nt103">c</xref> iHS <sub>(ASN)</sub>  = −1.24<xref ref-type="table-fn" rid="nt103">c</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>CYB5R4</italic></bold> (rs1325471)</td>
<td align="left" rowspan="1" colspan="1">Near a T2D susceptibility locus on Chr. 6</td>
<td align="left" rowspan="1" colspan="1">Chr. 6, 84624k</td>
<td align="left" rowspan="1" colspan="1">0.143</td>
<td align="left" rowspan="1" colspan="1">0.958</td>
<td align="left" rowspan="1" colspan="1">0.715</td>
<td align="left" rowspan="1" colspan="1">F<sub>ST (YRI-CEU)</sub>  = 0.77<xref ref-type="table-fn" rid="nt102">b</xref> F<sub>ST (YRI-ASN)</sub>  = 0.45 F<sub>ST (CEU-ASN)</sub>  = 0.19</td>
<td align="left" rowspan="1" colspan="1">A/G</td>
<td align="left" rowspan="1" colspan="1">iHS <sub>(YRI)</sub>  = 1.41<xref ref-type="table-fn" rid="nt103">c</xref> iHS <sub>(CEU)</sub>  = 0.43 iHS <sub>(ASN)</sub>  = −0.41</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>GAD2</italic></bold> (rs2236418)</td>
<td align="left" rowspan="1" colspan="1">OB, alcohol dependence, schizophrenia</td>
<td align="left" rowspan="1" colspan="1">Chr. 10, 26545k</td>
<td align="left" rowspan="1" colspan="1">0.126</td>
<td align="left" rowspan="1" colspan="1">0.836</td>
<td align="left" rowspan="1" colspan="1">0.704</td>
<td align="left" rowspan="1" colspan="1">F<sub>ST (YRI-CEU)</sub>  = 0.67<xref ref-type="table-fn" rid="nt102">b</xref> F<sub>ST (YRI-ASN)</sub>  = 0.51 F<sub>ST (CEU-ASN)</sub>  = 0.04</td>
<td align="left" rowspan="1" colspan="1">G/A</td>
<td align="left" rowspan="1" colspan="1">iHS <sub>(YRI)</sub>  = −1.16<xref ref-type="table-fn" rid="nt103">c</xref> iHS <sub>(CEU)</sub>  = 0.92<xref ref-type="table-fn" rid="nt103">c</xref> iHS <sub>(ASN)</sub>  = 0.48</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>PPARG</italic></bold> (rs2920502)</td>
<td align="left" rowspan="1" colspan="1">T2D, obesity, coronary artery diseases</td>
<td align="left" rowspan="1" colspan="1">Chr. 3, 12304k</td>
<td align="left" rowspan="1" colspan="1">0.026</td>
<td align="left" rowspan="1" colspan="1">0.357</td>
<td align="left" rowspan="1" colspan="1">0.753</td>
<td align="left" rowspan="1" colspan="1">F<sub>ST (YRI-CEU)</sub>  = 0.28 F<sub>ST (YRI-ASN)</sub>  = 0.76<xref ref-type="table-fn" rid="nt102">b</xref> F<sub>ST (CEU-ASN)</sub>  = 0.27</td>
<td align="left" rowspan="1" colspan="1">C/G</td>
<td align="left" rowspan="1" colspan="1">iHS <sub>(YRI)</sub>  =  N.D. iHS <sub>(CEU)</sub>  = 0.52 iHS <sub>(ASN)</sub>  = 0.61</td>
</tr>
<tr>
<td colspan="9" align="left" rowspan="1"><bold>Known type 2 diabetes- and GDM-associated intronic variants</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>CDKAL1</italic></bold> (rs7754840)</td>
<td align="left" rowspan="1" colspan="1">T2D, ulcerative colitis, GDM, Crohn's, OB</td>
<td align="left" rowspan="1" colspan="1">Chr. 6, 20769k</td>
<td align="left" rowspan="1" colspan="1">0.667</td>
<td align="left" rowspan="1" colspan="1">0.336</td>
<td align="left" rowspan="1" colspan="1">0.405</td>
<td align="left" rowspan="1" colspan="1">F<sub>ST (YRI-CEU)</sub>  = 0.18 F<sub>ST (YRI-ASN)</sub>  = 0.10 F<sub>ST (CEU-ASN)</sub>  = 0.02</td>
<td align="left" rowspan="1" colspan="1">G/C</td>
<td align="left" rowspan="1" colspan="1">iHS <sub>(YRI)</sub>  = 0.44 iHS <sub>(CEU)</sub>  = 0.04 iHS <sub>(ASN)</sub>  = −0.90<xref ref-type="table-fn" rid="nt103">c</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>CDKAL1</italic></bold> (rs7756992)</td>
<td align="left" rowspan="1" colspan="1">T2D, ulcerative colitis, GDM, Crohn's, OB</td>
<td align="left" rowspan="1" colspan="1">Chr6, 20787k</td>
<td align="left" rowspan="1" colspan="1">0.418</td>
<td align="left" rowspan="1" colspan="1">0.721</td>
<td align="left" rowspan="1" colspan="1">0.496</td>
<td align="left" rowspan="1" colspan="1">F<sub>ST (YRI-CEU)</sub>  = 0.23 F<sub>ST (YRI-ASN)</sub>  = 0.03 F<sub>ST (CEU-ASN)</sub>  = 0.10</td>
<td align="left" rowspan="1" colspan="1">G/A</td>
<td align="left" rowspan="1" colspan="1">iHS <sub>(YRI)</sub>  = 0.53 iHS <sub>(CEU)</sub>  = 0.13 iHS <sub>(ASN)</sub>  = 0.50</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label>a</label><p> T2D  =  Type 2 diabetes; GDM  =  Gestational diabetes mellitus; OB  =  obesity.</p></fn><fn id="nt102"><label>b</label><p> Significant F<sub>ST</sub>, which is defined as higher than 95<sup>th</sup> percentile of F<sub>ST</sub> of common SNPs in the HapMap populations.</p></fn><fn id="nt103"><label>c</label><p> Significant iHS assessed using coalescent simulations (see <xref ref-type="sec" rid="s2">Methods</xref>). iHS has not been determined (N.D.) for SNPs with a minor allele frequency &lt;0.10.</p></fn></table-wrap-foot></table-wrap>
<p>Analysis of F<sub>ST</sub> statistics indicated that the frequency of the derived <italic>CYB5R4</italic> rs1325471 and <italic>GAD2</italic> rs2236418 alleles in CEU, and the frequency of the derived <italic>PPARG</italic> rs2920502 allele in ASN are significantly different from those of YRI (<xref ref-type="fig" rid="pone-0105410-g001">Fig. 1</xref>; <xref ref-type="table" rid="pone-0105410-t001">Table 1</xref>, <italic>p</italic>&lt;.05). Consistently, analysis of LD showed that the genomic regions surrounding <italic>CDKAL1</italic> rs9368197, <italic>GAD2</italic> rs2236418, and <italic>PPARG</italic> rs2920502 are characterized by long LD blocks in CEU and ASN (Fig. S2, a-c in <xref ref-type="supplementary-material" rid="pone.0105410.s001">File S1</xref>). On the other hand, there is no appreciable difference in LD block characteristics surrounding <italic>CYB5R4</italic> rs1325471 among populations (Fig. S2d in <xref ref-type="supplementary-material" rid="pone.0105410.s001">File S1</xref>).</p>
<fig id="pone-0105410-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0105410.g001</object-id><label>Figure 1</label><caption>
<title>Differential distribution of <italic>CYB5R4, GAD2</italic>, and <italic>PPARG</italic> variants in human populations.</title>
<p>The distribution of the F<sub>ST</sub> for common SNPs across the human genome and the F<sub>ST</sub> for rs1325471, rs2236418, and rs2920502. For rs1325471 and rs2236418, F<sub>ST</sub> estimations between YRI and CEU (<bold>a-b</bold>) are shown on the <italic>x</italic>-axis. For rs2920502, comparisons between YRI and ASN (<bold>c</bold>) are shown on the <italic>x</italic>-axis. The black arrows indicate the corresponding values of F<sub>ST</sub> for the candidate variant. The <italic>y</italic>-axis represents the frequency of SNPs with a given F<sub>ST</sub> estimate. Significant F<sub>ST</sub>, which is defined as higher than 95<sup>th</sup> percentile of F<sub>ST</sub> of all common SNPs of HapMap populations, is indicated by an asterisk.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0105410.g001" position="float" xlink:type="simple"/></fig>
<p>Measurements of the iHS statistic using coalescent simulations in HapMap populations with a &gt;10% derived allele frequency showed that the derived <italic>CDKAL1</italic> rs9368197 allele exhibits significant EHH as compared to the ancestral allele in CEU and ASN <xref ref-type="bibr" rid="pone.0105410-Voight1">[4]</xref>, <xref ref-type="bibr" rid="pone.0105410-Sabeti1">[18]</xref>(<xref ref-type="fig" rid="pone-0105410-g002">Fig. 2a</xref>). The derived <italic>CDKAL1</italic> rs9368197 allele-associated haplotypes spanned approximately 150 kb, and the frequency of two 90-kb-long derived haplotypes increased from negligible in YRI to more than 53% in ASN (Fig. S3 in <xref ref-type="supplementary-material" rid="pone.0105410.s001">File S1</xref>, upper panel). Likewise, the ancestral <italic>CYB5R4</italic> rs1325471 allele exhibited EHH in the YRI (<xref ref-type="fig" rid="pone-0105410-g002">Fig. 2b</xref>) whereas the ancestral and derived alleles at rs2236418 of <italic>GAD2</italic> exhibited EHH in CEU and YRI, respectively (<xref ref-type="fig" rid="pone-0105410-g002">Fig. 2c</xref>). By contrast, rs2920502 of <italic>PPARG</italic> did not exhibit appreciable EHH (<xref ref-type="fig" rid="pone-0105410-g002">Fig. 2d</xref>).</p>
<fig id="pone-0105410-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0105410.g002</object-id><label>Figure 2</label><caption>
<title>Haplotype diversity surrounding <italic>CDKAL1, CYB5R4</italic>, and <italic>GAD2</italic> variants is allele-dependent in select populations.</title>
<p>Plots of iHS over the distance between selected variants and neighboring SNPs at increasing distances in YRI, CEU, and ASN populations (rs9368197 [<bold>a</bold>], rs1325471 [<bold>b</bold>], rs2236418 [<bold>c</bold>], rs292502 [<bold>d</bold>], rs7754840 [<bold>e</bold>], and rs7756992 [<bold>f</bold>]). A significant difference in EHH decay between the derived allele and the ancestral allele is indicated by an asterisk. The candidate variant is positioned at the center of the plots.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0105410.g002" position="float" xlink:type="simple"/></fig>
<p>Because two intronic <italic>CDKAL1</italic> variants (rs7754840 and rs7756992) that are positioned close to rs9368197 have been associated with type 2 diabetes and GDM in GWA studies <xref ref-type="bibr" rid="pone.0105410-Cho1">[25]</xref>, <xref ref-type="bibr" rid="pone.0105410-Lauenborg1">[26]</xref>, <xref ref-type="bibr" rid="pone.0105410-Wang1">[27]</xref>, <xref ref-type="bibr" rid="pone.0105410-Kwak1">[28]</xref>, we also analyzed the genetic patterns surrounding these two variants (<xref ref-type="fig" rid="pone-0105410-g002">Fig. 2, e-f</xref>) <xref ref-type="bibr" rid="pone.0105410-Pascoe1">[8]</xref>, <xref ref-type="bibr" rid="pone.0105410-Steinthorsdottir1">[9]</xref>, <xref ref-type="bibr" rid="pone.0105410-Cho1">[25]</xref>, <xref ref-type="bibr" rid="pone.0105410-Lauenborg1">[26]</xref>. Although the allele frequencies of these variants were similar among HapMap populations (<xref ref-type="table" rid="pone-0105410-t001">Table 1</xref>), the derived allele of rs7754840, but not rs7756992, exhibited a significant EHH in ASN (<xref ref-type="fig" rid="pone-0105410-g002">Fig. 2e</xref>).</p>
<p>Taken together, these data indicated that directional selection resulted in the spread of the derived rs9368197 and rs7754840 alleles of <italic>CDKAL1</italic>, the ancestral rs2236418 allele of <italic>GAD2</italic>, and the derived rs2920502 allele of <italic>PPARG</italic> in CEU and/or ASN populations. On the other hand, the ancestral <italic>CYB5R4</italic> rs1325471 allele and the derived <italic>GAD2</italic> rs2236418 allele were selected in YRI populations.</p>
</sec><sec id="s3b">
<title>Common <italic>CDKAL1</italic> variants rs9368197 and rs7754840 impart variations in glucose-induced insulin and GIP response, respectively, in pregnant women</title>
<p>Because pregnancy represents a critical life stage that subjects individuals to excessive metabolic load, and its success has a major impact on reproductive fitness, we chose to analyze the relationships among candidate variants and serum levels of GIP, insulin, and C-peptide in pregnant women with the hope that it would provide a sensitive model to uncover potential genotype–phenotype relationships.</p>
<p>The frequency of candidate SNPs in the study population was similar to that in ASN (<xref ref-type="table" rid="pone-0105410-t002">Table 2</xref>), and was in the Hardy–Weinberg equilibrium. Measurements of serum hormone levels showed that levels of insulin, but not GIP or C-peptide, in patients who are homozygous for the derived T allele of rs9368197 (i.e., <italic>CDKAL1<sup>−1305T/T</sup></italic>, <italic>N</italic> = 36) are significantly lower than those carrying an ancestral rs9368197 allele (i.e., <italic>CDKAL1<sup>−1305G/G</sup></italic> and <italic>CDKAL1<sup>−1305G/T</sup></italic>, <italic>N</italic> = 89)(<xref ref-type="fig" rid="pone-0105410-g003">Fig. 3a</xref>; <xref ref-type="table" rid="pone-0105410-t002">Table 2</xref>).</p>
<fig id="pone-0105410-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0105410.g003</object-id><label>Figure 3</label><caption>
<title>Genotypes of rs9368197 and rs7754840 in <italic>CDKAL1</italic> impart a difference in glucose-induced insulin and GIP response, respectively, after glucose challenge tests.</title>
<p><bold>a</bold>) Measurements of serum insulin levels in patients during the 23<sup>rd</sup> to the 29<sup>th</sup> weeks of pregnancy at 1 hr after the 50-gram glucose challenge test. Levels of insulin in patients who were homozygous for the derived T allele of rs9368197 (28.8±3.1 mU/L, <italic>N</italic> = 36) were significantly lower than those of patients carrying the ancestral G allele (i.e., heterozygotes and ancestral allele homozygotes, 42.8±3.7 mU/L, <italic>N</italic> = 89). <bold>b</bold>) Measurements of serum GIP levels in patients during the 23<sup>rd</sup> to the 29<sup>th</sup> weeks of pregnancy at 1 hr after the 50-gram glucose challenge test. Circulating levels of GIP in patients who were homozygous for the ancestral G allele of rs7754840 (68.9±4.5 pg/ml, <italic>N</italic>  = 54) were significantly lower than were those of patients carrying a derived C allele (i.e., heterozygotes and derived allele homozygotes, 82.8±4.5 pg/ml, <italic>N</italic> = 65). Serum hormone levels are presented as mean ± SEM.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0105410.g003" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0105410-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0105410.t002</object-id><label>Table 2</label><caption>
<title>Association between selected SNPs and hormonal responses after glucose challenge tests in pregnant women.</title>
</caption><alternatives><graphic id="pone-0105410-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0105410.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Gene (Candidate SNPs)</td>
<td align="left" rowspan="1" colspan="1">Frequency of alleles (anc/der)</td>
<td align="left" rowspan="1" colspan="1">Insulin (mU/L)</td>
<td align="left" rowspan="1" colspan="1">GIP (pg/ml)</td>
<td align="left" rowspan="1" colspan="1">C-peptide (ng/ml)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">Mean ± SD [N] (<italic>p</italic> value)<xref ref-type="table-fn" rid="nt104">a</xref></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>CDKAL1</italic></bold> (rs9368197)</td>
<td align="left" rowspan="1" colspan="1">G 0.452/T 0.548</td>
<td align="left" rowspan="1" colspan="1">GG 38.5±30.4 [24] (0.953)</td>
<td align="left" rowspan="1" colspan="1">GG 82.3±38.7 [25] (0.386)</td>
<td align="left" rowspan="1" colspan="1">GG 2.04±1.07 [25] (0.890)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">GT 44.5±38.8 [65]</td>
<td align="left" rowspan="1" colspan="1">GT 75.2±34.6 [59]</td>
<td align="left" rowspan="1" colspan="1">GT 2.19±1.18 [66]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><bold>TT 28.8±18.8 [36]</bold><bold> (0.005)</bold><xref ref-type="table-fn" rid="nt105">b</xref></td>
<td align="left" rowspan="1" colspan="1">TT 74.4±34.0 [36] (0.674)</td>
<td align="left" rowspan="1" colspan="1">TT 1.87±0.71 [37] (0.111)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>CYB5R4</italic></bold> (rs1325471)</td>
<td align="left" rowspan="1" colspan="1">A 0.300/G 0.700</td>
<td align="left" rowspan="1" colspan="1">AA 35.8±22.2 [13] (0.570)</td>
<td align="left" rowspan="1" colspan="1">AA 81.9±27.8 [14] (0.500)</td>
<td align="left" rowspan="1" colspan="1">AA 2.03±1.05 [14] (0.857)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">AG 40.0±33.3 [49]</td>
<td align="left" rowspan="1" colspan="1">AG 75.1±38.8 [46]</td>
<td align="left" rowspan="1" colspan="1">AG 2.11±1.06 [50]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">GG 39.7±34.5 [63] (0.917)</td>
<td align="left" rowspan="1" colspan="1">GG 77.1±34.8 [59] (0.952)</td>
<td align="left" rowspan="1" colspan="1">GG 2.07±1.07 [64] (0.890)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>GAD2</italic></bold> (rs2236418)</td>
<td align="left" rowspan="1" colspan="1">G 0.290/A 0.710</td>
<td align="left" rowspan="1" colspan="1">GG 48.3±49.1 [10] (0.523)</td>
<td align="left" rowspan="1" colspan="1">GG 72.2±42.1 [9] (0.637)</td>
<td align="left" rowspan="1" colspan="1"><bold>GG 1.45±0.79 [10]</bold><bold> (0.027)</bold><xref ref-type="table-fn" rid="nt106">c</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">GA 39.4±29.1 [53]</td>
<td align="left" rowspan="1" colspan="1">GA 80.2±36.0 [51]</td>
<td align="left" rowspan="1" colspan="1">GA 2.12±1.13 [52]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">AA 36.6±30.8 [63] (0.456)</td>
<td align="left" rowspan="1" colspan="1">AA 78.5±41.7 [62] (0.940)</td>
<td align="left" rowspan="1" colspan="1">AA 2.12±1.00 [66] (0.571)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>PPARG</italic></bold> (rs2920502)</td>
<td align="left" rowspan="1" colspan="1">C 0.222/G 0.778</td>
<td align="left" rowspan="1" colspan="1">CC 33.9±24.4 [6] (0.601)</td>
<td align="left" rowspan="1" colspan="1">CC 85.2±46.4 [6] (0.666)</td>
<td align="left" rowspan="1" colspan="1">CC 1.70±1.50 [6] (0.785)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">CG 43.8±35.2 [44]</td>
<td align="left" rowspan="1" colspan="1">CG 83.1±38.9 [44]</td>
<td align="left" rowspan="1" colspan="1">CG 2.26±1.08 [45]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">GG 37.2±31.7 [76] (0.378)</td>
<td align="left" rowspan="1" colspan="1">GG 72.3±30.8 [71] (0.103)</td>
<td align="left" rowspan="1" colspan="1">GG 2.00±1.00 [77] (0.319)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold><italic>CDKAL1</italic></bold> (rs7754840)</td>
<td align="left" rowspan="1" colspan="1">G 0.669/C 0.331</td>
<td align="left" rowspan="1" colspan="1">GG 36.1±29.7 [57] (0.394)</td>
<td align="left" rowspan="1" colspan="1"><bold>GG 68.9±32.8 [54]</bold><bold> (0.030)</bold><xref ref-type="table-fn" rid="nt106">c</xref></td>
<td align="left" rowspan="1" colspan="1">GG 2.02±0.95 [59] (0.606)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">GC 42.0±36.4 [52]</td>
<td align="left" rowspan="1" colspan="1">GC 78.0±34.4 [50]</td>
<td align="left" rowspan="1" colspan="1">GC 2.19±1.21 [53]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">CC 37.6±23.5 [15] (0.851)</td>
<td align="left" rowspan="1" colspan="1"><bold>CC 98.9.±37.4 [15]</bold><bold> (0.026)</bold><xref ref-type="table-fn" rid="nt105">b</xref></td>
<td align="left" rowspan="1" colspan="1">CC 1.84±0.83 [15] (0.485)</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt104"><label>a</label><p> <italic>p</italic> values of comparisons between a homozygous genotype, and those with a heterozygous or an opposite homozygous genotype (Student's <italic>t</italic>-test).</p></fn><fn id="nt105"><label>b</label><p> Significantly different from the averages of those with a heterozygous or a homozygous ancestral genotype. (<italic>p</italic>&lt;0.05).</p></fn><fn id="nt106"><label>c</label><p> Significantly different from the averages of those with a heterozygous or a homozygous derived genotype (<italic>p</italic>&lt;0.05).</p></fn></table-wrap-foot></table-wrap>
<p>On the other hand, circulating GIP level in patients who are homozygous for the ancestral G allele of rs7754840 (i.e., <italic>CDKAL1<sup>+12656G/G</sup></italic>, <italic>N</italic> = 54) was significantly lower than that of those carrying a derived C allele (i.e., <italic>CDKAL1<sup>+126562C/C</sup></italic> and <italic>CDKAL1<sup>+126562G/C</sup></italic>, <italic>N</italic> = 65)(<xref ref-type="fig" rid="pone-0105410-g003">Fig. 3b</xref>; <xref ref-type="table" rid="pone-0105410-t002">Table 2</xref>). Consistently, circulating GIP level in patients who are homozygous for the derived rs7754840 C allele (i.e., <italic>CDKAL1<sup>+12656C/C</sup></italic>, <italic>N</italic> = 15) was significantly higher than that of those carrying an ancestral G allele (i.e., <italic>CDKAL1<sup>+126562G/G</sup></italic> and <italic>CDKAL1<sup>+126562G/C</sup></italic>, <italic>N</italic> = 104)(<xref ref-type="table" rid="pone-0105410-t002">Table 2</xref>). In addition, linear regression analysis showed that the derived <italic>CDKAL1</italic> rs7754840 allele is associated with an enhanced glucose-induced GIP response with an R<sup>2</sup> = 0.046 (<italic>p</italic> = 0.018).</p>
<p>Furthermore, patients who are homozygous for the ancestral G allele of <italic>GAD2</italic> rs2236418 (<italic>GAD2<sup>−243G/G</sup></italic>, <italic>N</italic> = 10) had a significantly lower circulating level of C-peptide compared with those carrying a derived A allele (<italic>GAD2<sup>−243G/A</sup></italic> and <italic>GAD2<sup>−243A/A</sup></italic>, <italic>N</italic> = 118)(<xref ref-type="table" rid="pone-0105410-t002">Table 2</xref>). By contrast, the <italic>CBY5R4</italic> and <italic>PPARG</italic> variants did not have any significant relationship with serum insulin, GIP, or C-peptide levels.</p>
</sec><sec id="s3c">
<title>The type 2 diabetes/GDM risk variant of <italic>CDKAL1</italic> rs7754840 emerged ∼6,900 years ago in East Asians</title>
<p>To better understand putative events that led to the selection of <italic>CDKAL1</italic> variants, we estimated the age of selection based on coalescent simulations <xref ref-type="bibr" rid="pone.0105410-Stephens1">[20]</xref>, <xref ref-type="bibr" rid="pone.0105410-Reich1">[21]</xref>, <xref ref-type="bibr" rid="pone.0105410-Nei1">[29]</xref>, <xref ref-type="bibr" rid="pone.0105410-Kimura1">[30]</xref>. Scanning of the LD map and haplotype structures showed that informative SNPs surrounding rs9368197 are too sparse for reliable age determination. On the other hand, rs7754840 is located in a 151-kb-long LD block, bound between rs6927481 and rs7741604 in the ASN (Fig. S1 in <xref ref-type="supplementary-material" rid="pone.0105410.s001">File S1</xref>, upper left panel). Using the recombination map of the HapMap project <xref ref-type="bibr" rid="pone.0105410-TheInternationalHapMapProject1">[14]</xref>, <xref ref-type="bibr" rid="pone.0105410-McVean1">[22]</xref>, we interpolated the values of accumulative recombination at the positions of the two boundary SNPs of the LD block and took the difference between the two values (0.0946 cM; i.e., 0.0946% chance of crossing over per generation) as the recombination fraction for the region. This was translated into a recombination rate <italic>r</italic> = 9.46×10<sup>−4</sup>. Using the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0105410.e002" xlink:type="simple"/></inline-formula> equation, we obtained a generation estimate <italic>G</italic> = 276. An estimated generation time of 25 years indicated that the age of selection for rs7754840 is ∼6,900 years (<xref ref-type="fig" rid="pone-0105410-g004">Fig. 4</xref>).</p>
<fig id="pone-0105410-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0105410.g004</object-id><label>Figure 4</label><caption>
<title><italic>CDKAL1</italic> and <italic>GIP</italic> variants were selected in recent human history.</title>
<p>Schematic representation of the selection of multiple <italic>CDKAL1</italic> and <italic>GIP</italic> variants in ASN population <xref ref-type="bibr" rid="pone.0105410-Chang1">[5]</xref>, <xref ref-type="bibr" rid="pone.0105410-Chang2">[6]</xref>. The selection of <italic>CDKAL1</italic> and <italic>GIP</italic> variants appeared to occur independently within a 1,200-year time window in the last ten thousand years. The effects of these selections on enteroinsular hormonal responses are indicated by red arrows. The actions of hormones are indicated by black arrows.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0105410.g004" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s4">
<title>Discussion</title>
<p>Based on an analysis of the evolutionary history of candidate genes, we showed that common 5′ variants in <italic>CDKAL1</italic>, <italic>CYB5R4, GAD2</italic>, and <italic>PPARG</italic> as well as an intronic type 2 diabetes-associated <italic>CDKAL1</italic> variant exhibit non-neutral evolutionary patterns. In addition, we found that <italic>CDKAL1</italic> and <italic>GAD2</italic> variants are associated with glucose-induced insulin, GIP, or C-peptide responses in pregnant women. Together with our earlier studies of adaptive <italic>GIP</italic> variants <xref ref-type="bibr" rid="pone.0105410-Chang1">[5]</xref>, <xref ref-type="bibr" rid="pone.0105410-Chang2">[6]</xref>, these data provided strong evidence that the GIP-insulin-glucose axis is a hotspot for energy-balance regulation-associated selection (<xref ref-type="fig" rid="pone-0105410-g004">Fig. 4</xref>) <xref ref-type="bibr" rid="pone.0105410-McIntosha1">[31]</xref>.</p>
<p>A wide spectrum of physiological differences among humans are believed to be the result of positive selection of pre-existing variants and recent mutations that accumulated in response to environmental or cultural changes <xref ref-type="bibr" rid="pone.0105410-Voight1">[4]</xref>, <xref ref-type="bibr" rid="pone.0105410-Sabeti2">[32]</xref>. Recent advances have revealed adaptive SNPs that are associated with immune responses, changes in body forms (e.g., that affect the pigmentation of skin, hair, or eyes), and adaptations to extreme climates (e.g., the selection of the <italic>EPAS1</italic> gene in Tibetans) after humans spread to various parts of the world in the last 50–60 thousand years <xref ref-type="bibr" rid="pone.0105410-Leslie1">[1]</xref>, <xref ref-type="bibr" rid="pone.0105410-Simonson1">[2]</xref>, <xref ref-type="bibr" rid="pone.0105410-Tishkoff1">[3]</xref>, <xref ref-type="bibr" rid="pone.0105410-Voight1">[4]</xref>. However, the identification of adaptive variants in energy-balance regulation appeared to lag behind that of other traits <xref ref-type="bibr" rid="pone.0105410-Luca1">[33]</xref>, <xref ref-type="bibr" rid="pone.0105410-Pritchard1">[34]</xref>. Earlier studies have shown that variants in <italic>TCF7L2</italic> were positively selected, and were associated with BMI and levels of ghrelin and leptin; however, no general enrichment of adaptive variants in type 2 diabetes- and obesity-associated loci have been found <xref ref-type="bibr" rid="pone.0105410-Helgason1">[35]</xref>. On the other hand, a study of SNPs in 40 major human diseases indicated that a repertoire of type 2 diabetes risk alleles have a tendency for directional selection in Eurasians <xref ref-type="bibr" rid="pone.0105410-Chen1">[36]</xref>. It was speculated that this phenomenon could be associated with culture changes; however, the importance of this ensemble of “selection signal” in humans remains to be investigated. Consistent with these earlier studies, we found only a few SNPs that exhibit signals of selection. The paucity of adaptive SNPs in energy-balance regulation-associated genes could be due to heterogeneity in intensity, form, or time of environmental selection. In addition, recent culture changes that have subjected humans to varying degrees of population growth, and cycles of feast and famine could have made such variants retain only a minimal “signature of selection” <xref ref-type="bibr" rid="pone.0105410-Hancock1">[37]</xref>.</p>
<p>The finding that insulin levels are <italic>CDKAL1</italic> variant-dependent is not new. Intronic <italic>CDKAL1</italic> variants rs7754840, rs7756992, and rs10946398 have been associated with variations in insulin release, pancreatic cell functions, hemoglobin A1C level, and/or response to pancreatic KATP channel agonists <xref ref-type="bibr" rid="pone.0105410-Pascoe1">[8]</xref>, <xref ref-type="bibr" rid="pone.0105410-Miyaki1">[38]</xref>, <xref ref-type="bibr" rid="pone.0105410-OharaImaizumi1">[39]</xref> as well as type 2 diabetes, GDM, ulcerative colitis, Crohn's disease, obesity, and/or birth weight <xref ref-type="bibr" rid="pone.0105410-Steinthorsdottir1">[9]</xref>, <xref ref-type="bibr" rid="pone.0105410-Cho1">[25]</xref>, <xref ref-type="bibr" rid="pone.0105410-Lauenborg1">[26]</xref>, <xref ref-type="bibr" rid="pone.0105410-Kwak1">[28]</xref>. CDKAL1 has been shown to function as a tRNA modification enzyme, and its activity is associated with ATP generation and first-phase insulin secretion <xref ref-type="bibr" rid="pone.0105410-Xie2">[40]</xref>, <xref ref-type="bibr" rid="pone.0105410-Wei1">[41]</xref>, <xref ref-type="bibr" rid="pone.0105410-Wei2">[42]</xref>. The carriage of <italic>CDKAL1</italic> risk variants may lead to lower insulin release and impaired conversion of proinsulin to insulin in pancreatic beta cells <xref ref-type="bibr" rid="pone.0105410-Chistiakov1">[43]</xref>, <xref ref-type="bibr" rid="pone.0105410-Stancakova1">[44]</xref>, <xref ref-type="bibr" rid="pone.0105410-Kirchhoff1">[45]</xref>. Although the effect of derived rs9368197 allele on glucose-induced insulin response is similar to that reported for the derived rs7754840 allele, the finding that the derived rs7754840 allele (i.e., C) is associated with an elevated GIP response is unique because the same allele has been found to be associated with type 2 diabetes and reduced insulin secretion in earlier studies <xref ref-type="bibr" rid="pone.0105410-Chistiakov1">[43]</xref>, <xref ref-type="bibr" rid="pone.0105410-Stancakova1">[44]</xref>, <xref ref-type="bibr" rid="pone.0105410-Kirchhoff1">[45]</xref>, <xref ref-type="bibr" rid="pone.0105410-Dehwah1">[46]</xref>. These results suggest that the selection of derived rs7754840 allele has opposite effects on insulin secretion and glucose-induced GIP response. Because GIP's normal function is to stimulate insulin secretion, the adverse effect of derived rs7754840 allele on insulin metabolism may be counteracted by that on glucose-induced GIP response. Therefore, the reported association between <italic>CDKAL1</italic> variants and insulin metabolism could be partially affected by the rs7754840-associated GIP responses. In addition, the selection of the derived rs7754840 allele in East Asians may explain part of the observed differences in association strength between <italic>CDKAL1</italic> and type 2 diabetes among human populations <xref ref-type="bibr" rid="pone.0105410-Dehwah1">[46]</xref>. In corroboration with this idea, recent studies have reported that circulating GIP levels are highly familial compared to circulating levels of glucose, insulin, or C-peptide <xref ref-type="bibr" rid="pone.0105410-Gjesing1">[47]</xref>. Future study of the effect of CDKAL1 on GIP synthesis/secretion is needed to reveal whether CDKAL1 affects insulin secretion and GIP metabolism via a similar mechanism.</p>
<p>In a recent investigation, we documented the strong selection of a cluster of <italic>GIP</italic> variants in East Asians ∼8,100 (11,800 to 2,000) years ago <xref ref-type="bibr" rid="pone.0105410-Chang1">[5]</xref>, <xref ref-type="bibr" rid="pone.0105410-Chang2">[6]</xref>. It is surprising to find that the selection of rs7754840 in <italic>CDKAL1</italic> occurred in the same population at approximately the same time period (i.e., ∼6,900 years ago). Because the selection of <italic>CDKAL1</italic> and <italic>GIP</italic> variants overlapped, and because GIP metabolism is highly regulated during pregnancy <xref ref-type="bibr" rid="pone.0105410-Moffett1">[48]</xref>, we speculate that the regulation of enteroinsular axis in Eurasians was subject to strong environmental selection in recent human history (<xref ref-type="fig" rid="pone-0105410-g004">Fig. 4</xref>). Because no significant selection of SNPs was observed in other key enteroinsular regulatory genes—including insulin, insulin receptor, glucagon-like peptide-1 (GLP-1), GLP-1 receptor, glucagon, glucagon receptor, and GIP receptor—<italic>CDKAL1</italic> and <italic>GIP</italic> appear to be unique targets for energy-balance regulation-associated selections.</p>
<p>Although it is impossible to discern which environmental forces are responsible for the selection of <italic>CDKAL1</italic> and <italic>GIP</italic> variants, the selection of these variants during a period that heralded the agriculture revolution and animal domestication (i.e., 10,000 to 4,000 years ago following the Neolithic period) suggests that the selected <italic>CDKAL1</italic> and <italic>GIP</italic> variants may have facilitated the survival of their carriers in the face of changing subsistence culture. As culture again shifted in modern society, some of these prior advantageous adaptations (e.g., rs7754840) now may manifest as risk factors for type 2 diabetes and GDM <xref ref-type="bibr" rid="pone.0105410-Cho1">[25]</xref>, <xref ref-type="bibr" rid="pone.0105410-Wang1">[27]</xref>, <xref ref-type="bibr" rid="pone.0105410-Kwak1">[28]</xref>, <xref ref-type="bibr" rid="pone.0105410-Stancakova1">[44]</xref>, <xref ref-type="bibr" rid="pone.0105410-Kirchhoff1">[45]</xref>. In support of this view, recent studies have shown that minimal changes in subsistence patterns could have profound effects on the survival of individuals <xref ref-type="bibr" rid="pone.0105410-Ruff1">[49]</xref>. For example, it has been shown that feeding mice human-relevant concentrations of added sugar (i.e., 25% kcal from a mixture of fructose and glucose) is sufficient to increase mortality and reduce fertility even though such treatments have minimal effects on serum levels of cholesterol, fasting insulin, fasting glucose, or fasting triglycerides. Although our hypothesis cannot be falsified at the present time, future studies that consider Neanderthal and Denisovan genomes may provide further insight <xref ref-type="bibr" rid="pone.0105410-Crisci1">[50]</xref>.</p>
<p>Studies of hormonal profiles have also uncovered an association between <italic>GAD2</italic> rs2236418 and glucose-induced C-peptide response. Earlier studies have shown that polymorphisms of <italic>GAD2</italic>, which encodes an enzyme that catalyzes the production of gamma-aminobutyric acid (GABA), are associated with obesity, BMI, and postabsorptive resting energy expenditure in selected populations <xref ref-type="bibr" rid="pone.0105410-Witchel1">[10]</xref>, <xref ref-type="bibr" rid="pone.0105410-Chen2">[51]</xref>, <xref ref-type="bibr" rid="pone.0105410-Goossens1">[52]</xref>, <xref ref-type="bibr" rid="pone.0105410-Boesgaard1">[53]</xref>, <xref ref-type="bibr" rid="pone.0105410-Bannai1">[54]</xref>. GABA originating within the islets can evoke tonic currents, and decrease both insulin and glucagon secretion <xref ref-type="bibr" rid="pone.0105410-Bonaventura1">[55]</xref>, <xref ref-type="bibr" rid="pone.0105410-Braun1">[56]</xref>. In addition, the GABA signaling system has been shown to be compromised in islets of type 2 diabetes patients <xref ref-type="bibr" rid="pone.0105410-Taneera1">[57]</xref>. Therefore, the adaptive <italic>GAD2</italic> variant could indirectly contribute to variations in C-peptide, and perhaps insulin, metabolism by affecting GABA synthesis. Future study of the rs2236418-C-peptide relationship in other populations is needed to have a better understanding of the regulation of enteroinsular axis via neuronal signaling in humans.</p>
<p>Whereas <italic>CYB5R4</italic> and <italic>PPARG</italic> variants were not associated with the limited number of hormones that were analyzed, the “signals of selection” surrounding these variants warrant future investigations under different conditions. Among them, rs2920502 and linked SNPs like rs2920500 could be particularly interesting because <italic>PPARG</italic> has been associated with the development of type 2 diabetes, atherosclerosis, and cancer <xref ref-type="bibr" rid="pone.0105410-Hansen1">[7]</xref>, <xref ref-type="bibr" rid="pone.0105410-Tontonoz1">[58]</xref>, and because PPAR-γ agonists (e.g., thiazolidinedione) have been used to treat type 2 diabetes <xref ref-type="bibr" rid="pone.0105410-Tontonoz1">[58]</xref>. Likewise, future studies in patients of African or European origin may further reveal the role of selected <italic>CYB5R4</italic> and <italic>GAD2</italic> variants in the regulation of hormonal metabolism because these variants were selected in CEU and/or YRI.</p>
<p>In conclusion, the present study showed that adaptive <italic>CDKAL1</italic> variants could spread in Eurasians by contributing to alternative insulin or GIP responses. Therefore, environmental or culture changes in recent human history could have shaped the regulation of our enteroinsular axis to a greater extent than what has previously been assumed.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0105410.s001" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pone.0105410.s001" position="float" xlink:type="simple"><label>File S1</label><caption>
<p><bold>Figure S1. Plots of the haplotype structure of SNPs in a 151-kb LD block surrounding rs7754840 in the HapMap II populations.</bold> The 70 SNPs between rs6927481 and rs7741604 (151-kb in length) were linked, and displayed a low haplotype diversity in the ASN population (left upper panel). By contrast, the same region in the YRI chromosomes (right panel) exhibited a high complexity compared to the CEU and ASN populations. The position of rs7754840 is indicated by a vertical rectangular box. <bold>Figure S2. Variants in </bold><bold><italic>CDKAL1, GAD2</italic></bold><bold>, and </bold><bold><italic>PPARG</italic></bold><bold> are highly linked in select human populations.</bold> Plots of the degree of LD between each pair of genotyped SNPs in a 200-kb region surrounding the <italic>CDKAL1</italic> (a), <italic>GAD2</italic> (b), <italic>PPARG</italic> (c), and <italic>CYB5R4</italic> (d) loci in YRI, CEU, and ASN populations. The color scheme was based on r<sup>2</sup> values. Red areas represent regions with a high degree of LD and a high likelihood of odds (LOD) (D' = 1, LOD scores &gt;2). Blue areas represent regions with low LOD (D' = 1, LOD &lt;2). <bold>Figure S3. Haplotype structures of SNPs neighboring rs9368197 in the HapMap II populations.</bold> Plots of the haplotypes in a 200-kb genomic region (20,541-20,741 kb on chromosome 6) surrounding rs9368197 in <italic>CDKAL1</italic> showed that ASN chromosomes (upper panel) are characterized by a low-complexity structure whereas YRI chromosomes exhibit extensive recombinations (lower panel). The CEU chromosomes exhibited an intermediate pattern of complexity (middle panel). A 90-kb region with extensive haplotype homozygosity in ASN chromosomes is indicated by a red rectangular box in each of the three haplotype structure plots. The position of rs9368197 in each plot is indicated by a blue arrow.</p>
<p>(PDF)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>We thank Shripa Patel (Stanford University Pan Facility) and Wei Yi (Dept. of OB/GYN, Stanford University) for their excellent technical assistance.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0105410-Leslie1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leslie</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>Genetics. Kidney disease is parasite-slaying protein's downside</article-title>. <source>Science</source> <volume>329</volume>: <fpage>263</fpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Simonson1"><label>2</label>
<mixed-citation publication-type="other" xlink:type="simple">Simonson TS, Yang Y, Huff CD, Yun H, Qin G, <etal>et al</etal>.. (2010) Genetic Evidence for High-Altitude Adaptation in Tibet. Science May <volume>13</volume>..</mixed-citation>
</ref>
<ref id="pone.0105410-Tishkoff1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tishkoff</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Reed</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Ranciaro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Voight</surname><given-names>BF</given-names></name>, <name name-style="western"><surname>Babbitt</surname><given-names>CC</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Convergent adaptation of human lactase persistence in Africa and Europe</article-title>. <source>Nat Genet</source> <volume>39</volume>: <fpage>31</fpage>–<lpage>40</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Voight1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Voight</surname><given-names>BF</given-names></name>, <name name-style="western"><surname>Kudaravalli</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Pritchard</surname><given-names>JK</given-names></name> (<year>2006</year>) <article-title>A map of recent positive selection in the human genome</article-title>. <source>PLoS Biol</source> <volume>4</volume>: <fpage>e72</fpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Chang1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Chueh</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>SY</given-names></name> (<year>2011</year>) <article-title>Identification of metabolic modifiers that underlie phenotypic variations in energy-balance regulation</article-title>. <source>Diabetes</source> <volume>60</volume>: <fpage>726</fpage>–<lpage>734</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Chang2"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Lo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Amigo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JI</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Adaptive selection of an incretin gene in Eurasian populations</article-title>. <source>Genome Res</source> <volume>21</volume>: <fpage>21</fpage>–<lpage>32</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Hansen1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hansen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ekstrom</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Tabanera</surname><given-names>YPR</given-names></name>, <name name-style="western"><surname>Anant</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wassermann</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-gamma/alpha agonist-induced edema in type 2 diabetic patients</article-title>. <source>J Clin Endocrinol Metab</source> <volume>91</volume>: <fpage>3446</fpage>–<lpage>3450</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Pascoe1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pascoe</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tura</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Ibrahim</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Ferrannini</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function</article-title>. <source>Diabetes</source> <volume>56</volume>: <fpage>3101</fpage>–<lpage>3104</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Steinthorsdottir1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Steinthorsdottir</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Thorleifsson</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Reynisdottir</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Benediktsson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Jonsdottir</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A variant in CDKAL1 influences insulin response and risk of type 2 diabetes</article-title>. <source>Nat Genet</source> <volume>39</volume>: <fpage>770</fpage>–<lpage>775</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Witchel1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Witchel</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>White</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Libman</surname><given-names>I</given-names></name> (<year>2009</year>) <article-title>Association of the −243 A—&gt;G polymorphism of the glutamate decarboxylase 2 gene with obesity in girls with premature pubarche</article-title>. <source>Fertil Steril</source> <volume>91</volume>: <fpage>1869</fpage>–<lpage>1876</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Xie1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xie</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Larade</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ladoux</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Seguritan</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Absence of a reductase, NCB5OR, causes insulin-deficient diabetes</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>101</volume>: <fpage>10750</fpage>–<lpage>10755</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Boutin1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boutin</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Dina</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vasseur</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Dubois</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Corset</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>GAD2 on chromosome 10p12 is a candidate gene for human obesity</article-title>. <source>PLoS Biol</source> <volume>1</volume>: <fpage>E68</fpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Kjos1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kjos</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Buchanan</surname><given-names>TA</given-names></name> (<year>1999</year>) <article-title>Gestational diabetes mellitus</article-title>. <source>N Engl J Med</source> <volume>341</volume>: <fpage>1749</fpage>–<lpage>1756</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-TheInternationalHapMapProject1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">The-International-HapMap-Project, Frazer KA, Ballinger DG, Cox DR, Hinds DA, et al</collab> (<year>2007</year>) <article-title>A second generation human haplotype map of over 3.1 million SNPs</article-title>. <source>Nature</source> <volume>449</volume>: <fpage>851</fpage>–<lpage>861</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Cai1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cai</surname><given-names>JJ</given-names></name> (<year>2008</year>) <article-title>PGEToolbox: A Matlab toolbox for population genetics and evolution</article-title>. <source>J Hered</source> <volume>99</volume>: <fpage>438</fpage>–<lpage>440</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Amigo1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Amigo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Salas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Carracedo</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>SPSmart: adapting population based SNP genotype databases for fast and comprehensive web access</article-title>. <source>BMC Bioinformatics</source> <volume>9</volume>: <fpage>428</fpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Barrett1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barrett</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Fry</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Maller</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Daly</surname><given-names>MJ</given-names></name> (<year>2005</year>) <article-title>Haploview: analysis and visualization of LD and haplotype maps</article-title>. <source>Bioinformatics</source> <volume>21</volume>: <fpage>263</fpage>–<lpage>265</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Sabeti1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sabeti</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Reich</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Higgins</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Levine</surname><given-names>HZ</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>DJ</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Detecting recent positive selection in the human genome from haplotype structure</article-title>. <source>Nature</source> <volume>419</volume>: <fpage>832</fpage>–<lpage>837</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Hudson1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hudson</surname><given-names>RR</given-names></name> (<year>2002</year>) <article-title>Generating samples under a Wright-Fisher neutral model of genetic variation</article-title>. <source>Bioinformatics</source> <volume>18</volume>: <fpage>337</fpage>–<lpage>338</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Stephens1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stephens</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Reich</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Goldstein</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>MW</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes</article-title>. <source>Am J Hum Genet</source> <volume>62</volume>: <fpage>1507</fpage>–<lpage>1515</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Reich1"><label>21</label>
<mixed-citation publication-type="other" xlink:type="simple">Reich DE (1998) Estimating the age of mutations using variation at linked markers. Microsatellites: evolution and applications. Oxford: Oxford University Press. pp. 129–138.</mixed-citation>
</ref>
<ref id="pone.0105410-McVean1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McVean</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Hunt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Deloukas</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bentley</surname><given-names>DR</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>The fine-scale structure of recombination rate variation in the human genome</article-title>. <source>Science</source> <volume>304</volume>: <fpage>581</fpage>–<lpage>584</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Roach1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roach</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Glusman</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Smit</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Huff</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Hubley</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Analysis of genetic inheritance in a family quartet by whole-genome sequencing</article-title>. <source>Science</source> <volume>328</volume>: <fpage>636</fpage>–<lpage>639</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Gutenkunst1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gutenkunst</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Williamson</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Bustamante</surname><given-names>CD</given-names></name> (<year>2009</year>) <article-title>Inferring the joint demographic history of multiple populations from multidimensional SNP frequency data</article-title>. <source>PLoS Genet</source> <volume>5</volume>: <fpage>e1000695</fpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Cho1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cho</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>HD</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population</article-title>. <source>Diabetologia</source> <volume>52</volume>: <fpage>253</fpage>–<lpage>261</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Lauenborg1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lauenborg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Grarup</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Damm</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Borch-Johnsen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jorgensen</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Common type 2 diabetes risk gene variants associate with gestational diabetes</article-title>. <source>J Clin Endocrinol Metab</source> <volume>94</volume>: <fpage>145</fpage>–<lpage>150</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Wang1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nie</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Ping</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Association of six single nucleotide polymorphisms with gestational diabetes mellitus in a Chinese population</article-title>. <source>PLoS ONE</source> <volume>6</volume>: <fpage>e26953</fpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Kwak1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kwak</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Go</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>YS</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>A genome-wide association study of gestational diabetes mellitus in Korean women</article-title>. <source>Diabetes</source> <volume>61</volume>: <fpage>531</fpage>–<lpage>541</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Nei1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nei</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nozawa</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>The neutral theory of molecular evolution in the genomic era</article-title>. <source>Annu Rev Genomics Hum Genet</source> <volume>11</volume>: <fpage>265</fpage>–<lpage>289</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Kimura1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kimura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ota</surname><given-names>T</given-names></name> (<year>1973</year>) <article-title>The age of a neutral mutant persisting in a finite population</article-title>. <source>Genetics</source> <volume>75</volume>: <fpage>199</fpage>–<lpage>212</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-McIntosha1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McIntosha</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Widenmaiera</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S</given-names></name> (<year>2009</year>) <article-title>Glucose-Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP) Vitamins &amp; Hormones</article-title>. <volume>80</volume>: <fpage>409</fpage>–<lpage>471</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Sabeti2"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sabeti</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Varilly</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fry</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lohmueller</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hostetter</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Genome-wide detection and characterization of positive selection in human populations</article-title>. <source>Nature</source> <volume>449</volume>: <fpage>913</fpage>–<lpage>918</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Luca1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Luca</surname><given-names>F</given-names></name>, <name name-style="western"><surname>H</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>di Rienzo</surname><given-names>A</given-names></name> (<year>2010</year>) <article-title>Evolutionary Adaptatons to Dietary Changes</article-title>. <source>Annu Rev Nutr</source> <volume>30</volume>: <fpage>291</fpage>–<lpage>314</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Pritchard1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pritchard</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Pickrell</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Coop</surname><given-names>G</given-names></name> (<year>2010</year>) <article-title>The genetics of human adaptation: hard sweeps, soft sweeps, and polygenic adaptation</article-title>. <source>Curr Biol</source> <volume>20</volume>: <fpage>R208</fpage>–<lpage>215</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Helgason1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Helgason</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Palsson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Thorleifsson</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Grant</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Emilsson</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution</article-title>. <source>Nat Genet</source> <volume>39</volume>: <fpage>218</fpage>–<lpage>225</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Chen1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Corona</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sikora</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dudley</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Morgan</surname><given-names>AA</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases</article-title>. <source>PLoS Genet</source> <volume>8</volume>: <fpage>e1002621</fpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Hancock1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hancock</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Witonsky</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Ehler</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Alkorta-Aranburu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Beall</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Colloquium paper: human adaptations to diet, subsistence, and ecoregion are due to subtle shifts in allele frequency</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>107</volume> Suppl 2<fpage>8924</fpage>–<lpage>8930</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Miyaki1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miyaki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Oo</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lwin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tomita</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Association of a cyclin-dependent kinase 5 regulatory subunit-associated protein 1-like 1 (CDKAL1) polymorphism with elevated hemoglobin A(1)(c) levels and the prevalence of metabolic syndrome in Japanese men: interaction with dietary energy intake</article-title>. <source>Am J Epidemiol</source> <volume>172</volume>: <fpage>985</fpage>–<lpage>991</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-OharaImaizumi1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ohara-Imaizumi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Aoyagi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Okamura</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Deletion of CDKAL1 affects mitochondrial ATP generation and first-phase insulin exocytosis</article-title>. <source>PLoS ONE</source> <volume>5</volume>: <fpage>e15553</fpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Xie2"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xie</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>FY</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kaitsuka</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Quantitative PCR measurement of tRNA 2-methylthio modification for assessing type 2 diabetes risk</article-title>. <source>Clin Chem</source> <volume>59</volume>: <fpage>1604</fpage>–<lpage>1612</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Wei1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wei</surname><given-names>FY</given-names></name>, <name name-style="western"><surname>Tomizawa</surname><given-names>K</given-names></name> (<year>2011</year>) <article-title>Functional loss of Cdkal1, a novel tRNA modification enzyme, causes the development of type 2 diabetes</article-title>. <source>Endocr J</source> <volume>58</volume>: <fpage>819</fpage>–<lpage>825</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Wei2"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wei</surname><given-names>FY</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kimura</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kaitsuka</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice</article-title>. <source>J Clin Invest</source> <volume>121</volume>: <fpage>3598</fpage>–<lpage>3608</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Chistiakov1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chistiakov</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Potapov</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Smetanina</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Bel'chikova</surname><given-names>LN</given-names></name>, <name name-style="western"><surname>Suplotova</surname><given-names>LA</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel</article-title>. <source>Acta Diabetol</source> <volume>48</volume>: <fpage>227</fpage>–<lpage>235</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Stancakova1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stancakova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pihlajamaki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kuusisto</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Stefan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Fritsche</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance</article-title>. <source>J Clin Endocrinol Metab</source> <volume>93</volume>: <fpage>1924</fpage>–<lpage>1930</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Kirchhoff1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kirchhoff</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Machicao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Haupt</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schafer</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Tschritter</surname><given-names>O</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion</article-title>. <source>Diabetologia</source> <volume>51</volume>: <fpage>597</fpage>–<lpage>601</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Dehwah1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dehwah</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>QY</given-names></name> (<year>2010</year>) <article-title>CDKAL1 and type 2 diabetes: a global meta-analysis</article-title>. <source>Genet Mol Res</source> <volume>9</volume>: <fpage>1109</fpage>–<lpage>1120</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Gjesing1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gjesing</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Ekstrom</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Eiberg</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Urhammer</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Holst</surname><given-names>JJ</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits</article-title>. <source>Diabetologia</source> <volume>55</volume>: <fpage>1338</fpage>–<lpage>1345</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Moffett1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moffett</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Irwin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Francis</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Flatt</surname><given-names>PR</given-names></name> (<year>2013</year>) <article-title>Alterations of Glucose-Dependent Insulinotropic Polypeptide and Expression of Genes Involved in Mammary Gland and Adipose Tissue Lipid Metabolism during Pregnancy and Lactation</article-title>. <source>PLoS ONE</source> <volume>8</volume>: <fpage>e78560</fpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Ruff1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ruff</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Suchy</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Hugentobler</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Sosa</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>BL</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Human-relevant levels of added sugar consumption increase female mortality and lower male fitness in mice</article-title>. <source>Nat Commun</source> <volume>4</volume>: <fpage>2245</fpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Crisci1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crisci</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Good</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>JD</given-names></name> (<year>2011</year>) <article-title>On characterizing adaptive events unique to modern humans</article-title>. <source>Genome Biol Evol</source> <volume>3</volume>: <fpage>791</fpage>–<lpage>798</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Chen2"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Chao</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Chi</surname><given-names>SS</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Association of genetic polymorphisms of glutamate decarboxylase 2 and the dopamine D2 receptor with obesity in Taiwanese subjects</article-title>. <source>Ann Saudi Med</source> <volume>32</volume>: <fpage>121</fpage>–<lpage>126</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Goossens1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goossens</surname><given-names>GH</given-names></name>, <name name-style="western"><surname>Petersen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Blaak</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Hul</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Arner</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Several obesity- and nutrient-related gene polymorphisms but not FTO and UCP variants modulate postabsorptive resting energy expenditure and fat-induced thermogenesis in obese individuals: the NUGENOB study</article-title>. <source>Int J Obes (Lond)</source> <volume>33</volume>: <fpage>669</fpage>–<lpage>679</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Boesgaard1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boesgaard</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Castella</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Albrechtsen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sparso</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A -243A—&gt;G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population-based sample of 5857 middle-aged White subjects</article-title>. <source>Diabet Med</source> <volume>24</volume>: <fpage>702</fpage>–<lpage>706</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Bannai1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bannai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ichikawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nishihara</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>M</given-names></name> (<year>1998</year>) <article-title>Effect of injection of antisense oligodeoxynucleotides of GAD isozymes into rat ventromedial hypothalamus on food intake and locomotor activity</article-title>. <source>Brain Res</source> <volume>784</volume>: <fpage>305</fpage>–<lpage>315</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Bonaventura1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonaventura</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Crivello</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ferreira</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Repetto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cymeryng</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Effects of GABAB receptor agonists and antagonists on glycemia regulation in mice</article-title>. <source>Eur J Pharmacol</source> <volume>677</volume>: <fpage>188</fpage>–<lpage>196</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Braun1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Braun</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ramracheya</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bengtsson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>JN</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells</article-title>. <source>Diabetes</source> <volume>59</volume>: <fpage>1694</fpage>–<lpage>1701</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Taneera1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taneera</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Muhammed</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>gamma-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes</article-title>. <source>Diabetologia</source> <volume>55</volume>: <fpage>1985</fpage>–<lpage>1994</lpage>.</mixed-citation>
</ref>
<ref id="pone.0105410-Tontonoz1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tontonoz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Spiegelman</surname><given-names>BM</given-names></name> (<year>2008</year>) <article-title>Fat and beyond: the diverse biology of PPARgamma</article-title>. <source>Annu Rev Biochem</source> <volume>77</volume>: <fpage>289</fpage>–<lpage>312</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>